Arcturus Therapeutics (ARCT) had a challenging fourth quarter, with revenue and earnings falling short of analyst expectations. Their annual revenue took a dip, dropping $14.5 million from the ...
Try Now>> See the top stocks recommended by analysts >> Read More on ARCT: Arcturus Therapeutics Holdings NewsMORE Related Stocks Indices Commodities Currencies Stocks ...
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) missed earnings with its latest annual results, disappointing overly-optimistic forecasters. Unfortunately, Arcturus Therapeutics Holdings ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback